These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10605465)

  • 41. [Efficacy of inhaled zanamivir in the treatment and prevention of influenza].
    Abad-Santos F; Gallego Sandín S; Novalbos Reina J; Martínez Sancho E; Gálvez Múgica MA
    An Med Interna; 2001 Feb; 18(2):93-9. PubMed ID: 11322008
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rapid antiviral effect of inhaled zanamivir in the treatment of naturally occurring influenza in otherwise healthy adults.
    Boivin G; Goyette N; Hardy I; Aoki F; Wagner A; Trottier S
    J Infect Dis; 2000 Apr; 181(4):1471-4. PubMed ID: 10762579
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oseltamivir resistance in influenza A (H5N1) infection.
    Gupta RK; Nguyen-Van-Tam JS
    N Engl J Med; 2006 Mar; 354(13):1423-4; author reply 1423-4. PubMed ID: 16571890
    [No Abstract]   [Full Text] [Related]  

  • 44. Updated treatment for influenza A and B.
    Montalto NJ; Gum KD; Ashley JV
    Am Fam Physician; 2000 Dec; 62(11):2467-76. PubMed ID: 11130232
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [New diagnostic possibilities and medications. Fit for influenza?].
    Wutzler P
    MMW Fortschr Med; 2002 Nov; 144(48):18. PubMed ID: 12532540
    [No Abstract]   [Full Text] [Related]  

  • 46. Advances in pharmacology. New treatments for influenza: neuraminidase inhibitors.
    Cross J; Wedekind CA
    Med Health R I; 2001 Jun; 84(6):209-11. PubMed ID: 11434154
    [No Abstract]   [Full Text] [Related]  

  • 47. Influenza and the new antivirals: potential for misdiagnosis and possible misuse of antivirals.
    Lim S; Richardson D; Conly JM
    Can Commun Dis Rep; 2000 Dec; 26(23):202-5. PubMed ID: 11131689
    [No Abstract]   [Full Text] [Related]  

  • 48. [HIV, hepatitis, influenza: new antiviral agents].
    Dtsch Med Wochenschr; 1999 Jan; 124(1-2):A16. PubMed ID: 9951459
    [No Abstract]   [Full Text] [Related]  

  • 49. [Critical review of anti-influenza drugs].
    van Loon FP; Voordouw AC; Simonian S; Koopmans PP
    Ned Tijdschr Geneeskd; 2000 Jan; 144(4):165-7. PubMed ID: 10668542
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influenza--a new problem?
    Laver WG; Kelly GD
    Med J Aust; 1999 Nov; 171(9):504. PubMed ID: 10615357
    [No Abstract]   [Full Text] [Related]  

  • 51. Influenza virus and rhinovirus-related otitis media: potential for antiviral intervention.
    Hayden FG
    Vaccine; 2000 Dec; 19 Suppl 1():S66-70. PubMed ID: 11163466
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy and safety of zanamivir in patients with influenza--impact of age, severity of infections and specific risk factors.
    Höffken G; Gillissen A
    Med Microbiol Immunol; 2002 Dec; 191(3-4):169-73. PubMed ID: 12458354
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety and efficacy of the neuraminidase inhibitor zanamivir in treating influenza virus infection in adults: results from Japan. GG167 Group.
    Matsumoto K; Ogawa N; Nerome K; Numazaki Y; Kawakami Y; Shirato K; Arakawa M; Kudoh S; Shimokata K; Nakajima S; Yamakido M; Kashiwagi S; Nagatake T
    Antivir Ther; 1999; 4(2):61-8. PubMed ID: 10682150
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Flu drug approval means more work for nurses.
    Lipley N
    Nurs Stand; 2000 Nov 29-Dec 5; 15(11):9. PubMed ID: 11971577
    [No Abstract]   [Full Text] [Related]  

  • 55. [Influenza: from vaccine prevention to antiviral therapy].
    Nkoghe D; Scheen AJ
    Rev Med Liege; 2000 Jan; 55(1):19-23. PubMed ID: 10803033
    [TBL] [Abstract][Full Text] [Related]  

  • 56. NICE advises against prescribing zanamivir until further evidence emerges.
    Commun Dis Rep CDR Wkly; 1999 Oct; 9(42):371. PubMed ID: 10582390
    [No Abstract]   [Full Text] [Related]  

  • 57. Flu treatment. A new member of the armamentarium.
    Harv Health Lett; 1999 Nov; 25(1):3. PubMed ID: 10521901
    [No Abstract]   [Full Text] [Related]  

  • 58. Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group.
    Hayden FG; Gubareva LV; Monto AS; Klein TC; Elliot MJ; Hammond JM; Sharp SJ; Ossi MJ;
    N Engl J Med; 2000 Nov; 343(18):1282-9. PubMed ID: 11058672
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Surveillance for neuraminidase inhibitor resistance in human influenza viruses from Australia.
    Hurt AC; Barr IG; Durrant CJ; Shaw RP; Sjogren HM; Hampson AW
    Commun Dis Intell Q Rep; 2003; 27(4):542-7. PubMed ID: 15508516
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Zanamivir: a review of its use in influenza.
    Dunn CJ; Goa KL
    Drugs; 1999 Oct; 58(4):761-84. PubMed ID: 10551442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.